In 2021 and 2022, COVID-19 drug Veklury (remdesivir) was the No. 1 pharmaceutical expense for the nation’s hospitals. Most medicines on the list saw modest changes from the prior year except for TNKase (tenecteplase), a cardiovascular therapy that cost hospitals 87.9% more in 2023.
The research calculated healthcare drug expenditure among three factors: a drug’s list price, newly approved drugs and utilization.
The top 25 drugs ranked by nonfederal hospital expenditure in 2023:
Pembrolizumab — $1.4 billion (4.4% change from 2022)
Immune globulin — $1 billion (-5.1% change)
Remdesivir — $727,409,000 (-45% change)
Bictegravir/emtricitabine/tenofovir/alafenamide — $643,390,000 (18.9% change)
Sugammadex — $636,441,000 (23.9% change)
Pneumococcal vaccine conjugate — $585,635,000 (29.5% change)
Daratumumab/hyaluronidase — $584,128,000 (17.4% change)
Nivolumab — $551,518,000 (-6.4% change)
Inactivated influenza virus — $541,415,000 (-10% change)
Natalizumab — $503,380,000 (-12.8% change)
Ocrelizumab — $499,917,000 (-0.2% change)
Rituximab — $483,858,000 (-12.9% change)
Sodium intravenous solutions — $483,290,000 (8.2% change)
Antithymocyte immunoglobulin — $481,304,000 (6.5% change)
Alteplase — $475,445,000 (-24.2% change)
Denosumab — $430,814,000 (-0.1% change)
Iohexol — $358,330,000 (14.5% change)
Factor II/factor VII/ factor IX/factor x/protein C/protein S — $329,253,000 (10.2% change)
Vedolizumab — $312,172,000 (-2.1% change)
Tenecteplase — $311,081,000 (87.9% change)
Bupivacaine — $308,309,000 (-14.2% change)
Albumin — $308,166,000 (-11.3% change)
Iopamidol — $302,470,000 (-2.4% change)
Infliximab — $300,332,000 (-23.6% change)
Pegfilgrastim — $299,326,000 (-22.1% change)
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
